Outlook Therapeutics (OTLK) Revenue: 2015-2020
Historic Revenue for Outlook Therapeutics (OTLK) over the last 6 years, with Sep 2020 value amounting to -$19,031.
- Outlook Therapeutics' Revenue fell 100.33% to -$19,031 in Q3 2020 from the same period last year, while for Sep 2020 it was -$1.8 million, marking a year-over-year decrease of 121.56%. This contributed to the annual value of -$3.2 million for FY2024, which is 24.72% down from last year.
- Per Outlook Therapeutics' latest filing, its Revenue stood at -$19,031 for Q3 2020, which was up 95.71% from -$443,624 recorded in Q2 2020.
- Outlook Therapeutics' 5-year Revenue high stood at $5.9 million for Q3 2019, and its period low was -$696,151 during Q1 2020.
- In the last 3 years, Outlook Therapeutics' Revenue had a median value of $641,140 in 2019 and averaged $791,393.
- Per our database at Business Quant, Outlook Therapeutics' Revenue soared by 658.34% in 2019 and then crashed by 208.58% in 2020.
- Over the past 5 years, Outlook Therapeutics' Revenue (Quarterly) stood at $303,140 in 2016, then surged by 154.63% to $771,890 in 2017, then spiked by 38.31% to $1.1 million in 2018, then slumped by 155.98% to -$597,665 in 2019, then slumped by 100.33% to -$19,031 in 2020.
- Its Revenue stands at -$19,031 for Q3 2020, versus -$443,624 for Q2 2020 and -$696,151 for Q1 2020.